Evidence map›Paper›PMID 22363777›Full record

ArticlePloS one2012

A genome-wide study of cytogenetic changes in colorectal cancer using SNP microarrays: opportunities for future personalized treatment.

Farzana Jasmine, Ronald Rahaman, Charlotte Dodsworth, Shantanu Roy, Rupash Paul, Maruf Raza, Rachelle Paul-Brutus, Mohammed Kamal, Habibul Ahsan, Muhammad G Kibriya

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Association ofInternational journal of molecular sciences · 2024
    Article
  5. Harnessing deep learning for SNP-based disease prediction in genomics.International journal of information technology : an official journal of Bharati Vidyapeeth's Institute of Computer Applications and Management · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. RecurrentCancers · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Aurora Kinase A Is a Prognostic Marker in Colorectal Adenocarcinoma.Journal of pathology and translational medicine · 2017
    Article
  19. Unexpected frequency of genomic alterations in histologically normal colonic tissue from colon cancer patients.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  20. Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Farzana JasmineDepartment of Health Studies, The University of Chicago, Chicago, Illinois, United States of America.
Ronald Rahaman
Charlotte Dodsworth
Shantanu Roy
Rupash Paul
Maruf Raza
Rachelle Paul-Brutus
Mohammed Kamal
Habibul Ahsan
Muhammad G Kibriya
University of Chicago · USBangabandhu Sheikh Mujib Medical University · BD

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI MARK W. LINGEN · 1985 to 2026
$122.1M
Training CoreP42ES010349 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI NAVAS-ACIEN, ANA · 2000 to 2020
$53.6M
Chemoprevention of arsenic-induced skin cancerR01CA107431 · NCI · UNIVERSITY OF CHICAGO · PI AHSAN, HABIBUL · 2005 to 2014
$17.3M
Genomewide association in early-onset breast cancerU01CA122171 · NCI · UNIVERSITY OF CHICAGO · PI AHSAN, HABIBUL · 2006 to 2010
$7.2M
Genetic Susceptibility to Arsenic-induced Skin CancerR01CA102484 · NCI · UNIVERSITY OF CHICAGO · PI AHSAN, HABIBUL · 2004 to 2008
$2.0M
NCI NIH HHS P30 CA 014599NCI NIH HHS P30 CA014599NCI NIH HHS R01 CA102484NCI NIH HHS R01CA102484NCI NIH HHS R01 CA107431NCI NIH HHS R01CA107431NCI NIH HHS U01 CA122171NIEHS NIH HHS P42 ES010349NIEHS NIH HHS P42ES010349
6 · The paper itself

Abstract

In colorectal cancer (CRC), chromosomal instability (CIN) is typically studied using comparative-genomic hybridization (CGH) arrays. We studied paired (tumor and surrounding healthy) fresh frozen tissue from 86 CRC patients using Illumina's Infinium-based SNP array. This method allowed us to study CIN in CRC, with simultaneous analysis of copy number (CN) and B-allele frequency (BAF)--a representation of allelic composition. These data helped us to detect mono-allelic and bi-allelic amplifications/deletion, copy neutral loss of heterozygosity, and levels of mosaicism for mixed cell populations, some of which can not be assessed with other methods that do not measure BAF. We identified associations between CN abnormalities and different CRC phenotypes (histological diagnosis, location, tumor grade, stage, MSI and presence of lymph node metastasis). We showed commonalities between regions of CN change observed in CRC and the regions reported in previous studies of other solid cancers (e.g. amplifications of 20q, 13q, 8q, 5p and deletions of 18q, 17p and 8p). From Therapeutic Target Database, we identified relevant drugs, targeted to the genes located in these regions with CN changes, approved or in trials for other cancers and common diseases. These drugs may be considered for future therapeutic trials in CRC, based on personalized cytogenetic diagnosis. We also found many regions, harboring genes, which are not currently targeted by any relevant drugs that may be considered for future drug discovery studies. Our study shows the application of high density SNP arrays for cytogenetic study in CRC and its potential utility for personalized treatment.

Indexed as

Chromosome AberrationsPrecision MedicineAllelesChromosome DeletionChromosomes, Human, Pair 17Chromosomes, Human, Pair 8Colorectal NeoplasmsDatabases, GeneticFemaleGene DosageGenome, HumanGenome-Wide Association StudyHumansLoss of HeterozygosityMaleMiddle Aged

Identifiers

PMID22363777
PMCPMC3282791
OpenAlexW2037451457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.